JP2011509079A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509079A5 JP2011509079A5 JP2010540186A JP2010540186A JP2011509079A5 JP 2011509079 A5 JP2011509079 A5 JP 2011509079A5 JP 2010540186 A JP2010540186 A JP 2010540186A JP 2010540186 A JP2010540186 A JP 2010540186A JP 2011509079 A5 JP2011509079 A5 JP 2011509079A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- antibody
- affinity reagent
- receptor
- ephrin type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims 20
- 101710143005 Ephrin type-A receptor 10 Proteins 0.000 claims 14
- 102100021600 Ephrin type-A receptor 10 Human genes 0.000 claims 14
- 239000012634 fragment Substances 0.000 claims 13
- 201000010536 head and neck cancer Diseases 0.000 claims 10
- 208000014829 head and neck neoplasm Diseases 0.000 claims 10
- 206010005003 Bladder cancer Diseases 0.000 claims 9
- 206010006187 Breast cancer Diseases 0.000 claims 9
- 208000026310 Breast neoplasm Diseases 0.000 claims 9
- 206010009944 Colon cancer Diseases 0.000 claims 9
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 9
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 9
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 9
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 9
- 206010038389 Renal cancer Diseases 0.000 claims 9
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 9
- 201000010982 kidney cancer Diseases 0.000 claims 9
- 201000005202 lung cancer Diseases 0.000 claims 9
- 208000020816 lung neoplasm Diseases 0.000 claims 9
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 9
- 201000002528 pancreatic cancer Diseases 0.000 claims 9
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 9
- 201000005112 urinary bladder cancer Diseases 0.000 claims 9
- 239000000427 antigen Substances 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 238000000338 in vitro Methods 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 230000003278 mimic effect Effects 0.000 claims 5
- 108700022150 Designed Ankyrin Repeat Proteins Proteins 0.000 claims 4
- 229930193936 anticarin Natural products 0.000 claims 4
- 238000012544 monitoring process Methods 0.000 claims 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 3
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 3
- 230000002946 anti-pancreatic effect Effects 0.000 claims 3
- 239000003560 cancer drug Substances 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 230000003013 cytotoxicity Effects 0.000 claims 1
- 231100000135 cytotoxicity Toxicity 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 102000012803 ephrin Human genes 0.000 claims 1
- 108060002566 ephrin Proteins 0.000 claims 1
- 239000012642 immune effector Substances 0.000 claims 1
- 229940121354 immunomodulator Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US877507P | 2007-12-24 | 2007-12-24 | |
| PCT/IB2008/003634 WO2009087462A2 (en) | 2007-12-24 | 2008-12-24 | Ephrin type-a receptor 10 protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509079A JP2011509079A (ja) | 2011-03-24 |
| JP2011509079A5 true JP2011509079A5 (enExample) | 2012-02-16 |
Family
ID=40802031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010540186A Pending JP2011509079A (ja) | 2007-12-24 | 2008-12-24 | エフリンａ型受容体１０タンパク質 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8540998B2 (enExample) |
| EP (1) | EP2235055A2 (enExample) |
| JP (1) | JP2011509079A (enExample) |
| WO (1) | WO2009087462A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011047083A1 (en) * | 2009-10-13 | 2011-04-21 | Oxford Biotherapeutics Ltd. | Antibodies against epha10 |
| US8455200B2 (en) | 2009-10-15 | 2013-06-04 | Traxxsson, Llc | Measurement of PKA for cancer detection |
| WO2011054007A1 (en) | 2009-11-02 | 2011-05-05 | Oxford Biotherapeutics Ltd. | Ror1 as therapeutic and diagnostic target |
| AU2011299088B2 (en) | 2010-09-09 | 2015-12-24 | Traxxsson, Llc | Combination methods of diagnosing cancer in a patient |
| JP5956424B2 (ja) * | 2011-03-15 | 2016-07-27 | 国立研究開発法人医薬基盤・健康・栄養研究所 | 抗体、乳がんの治療に用いられる医薬組成物、腫瘍検査方法、及び、腫瘍検査用試薬 |
| LT2726094T (lt) | 2011-06-28 | 2017-02-10 | Oxford Biotherapeutics Ltd | Gydymo ir diagnozavimo objektas |
| GB201213652D0 (en) | 2012-08-01 | 2012-09-12 | Oxford Biotherapeutics Ltd | Therapeutic and diagnostic target |
| GB201302447D0 (en) | 2013-02-12 | 2013-03-27 | Oxford Biotherapeutics Ltd | Therapeutic and diagnostic target |
| ES2859604T3 (es) | 2013-10-11 | 2021-10-04 | Oxford Bio Therapeutics Ltd | Anticuerpos conjugados contra LY75 para el tratamiento del cáncer |
| GB201703876D0 (en) | 2017-03-10 | 2017-04-26 | Berlin-Chemie Ag | Pharmaceutical combinations |
| GB201809746D0 (en) | 2018-06-14 | 2018-08-01 | Berlin Chemie Ag | Pharmaceutical combinations |
| CN118632870A (zh) * | 2021-11-22 | 2024-09-10 | 洪明奇 | Ephrin a型受体10特异性抗体、表现其之嵌合抗原受体t细胞及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030096952A1 (en) | 2000-03-30 | 2003-05-22 | Kumud Majumder | Novel proteins and nucleic acids encoding same |
| ATE283287T1 (de) | 2000-07-26 | 2004-12-15 | Merck Patent Gmbh | Ein neues mitglied der epha-rezeptor familie |
| JP2003052384A (ja) | 2001-04-06 | 2003-02-25 | Takeda Chem Ind Ltd | 新規レセプタータンパク質及びそのｄｎａ |
| US20060040325A1 (en) | 2004-08-16 | 2006-02-23 | Medimmune, Inc. | Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity |
| WO2006047639A2 (en) | 2004-10-27 | 2006-05-04 | Medimmune, Inc. | Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| AU2006287416A1 (en) * | 2005-09-07 | 2007-03-15 | Medimmune, Llc | Toxin conjugated Eph receptor antibodies |
| WO2008066498A1 (en) * | 2006-12-01 | 2008-06-05 | Agency For Science, Technology And Research | Cancer-related protein kinases |
-
2008
- 2008-12-24 US US12/810,095 patent/US8540998B2/en not_active Expired - Fee Related
- 2008-12-24 JP JP2010540186A patent/JP2011509079A/ja active Pending
- 2008-12-24 WO PCT/IB2008/003634 patent/WO2009087462A2/en not_active Ceased
- 2008-12-24 EP EP08869234A patent/EP2235055A2/en not_active Withdrawn